Bloomios, Inc. Stock

BLMS

US0948571098

Healthcare Facilities & Services

Market Closed - OTC Markets 17:49:30 20/08/2026 +03			5-day change	1st Jan Change
0.000300 ^USD	-.--%		-.--%	+200.00%

31/05/24	Bloomios, Inc. Bankruptcy Case Dismissed	CI
15/04/24	Involuntary Petition Filed Against Bloomios, Inc.	CI

Bloomios, Inc. manufactures, markets and distributes United States hemp-derived supplements and cosmetic products through wholesale distribution channels in the United States of America, through its wholly owned subsidiary Bloomios Private Label (BPL). BPL is engaged in manufacturing, processing, sourcing and distribution of hemp-derived, nootropic and nutraceutical products to wholesalers and retailers. BPL provides support at each step from custom formulation, order fulfilment, and brand development. It offers its private-label and white-label customers large collections of customizable hemp products that include over 80 products across 10 categories in addition to custom formulation and manufacturing services. Its product categories include edibles, tinctures, oils, salves, capsules, balms, topicals, beverages and pet treats. It manufactures hemp infused products ranging from human edibles, pet edibles, liquid consumables such as tinctures and shots, and topicals.

Employees

Sector

Healthcare Facilities & Services

More about the company

Stock Market
Stocks
BLMS Stock

As early as today, start finding the best investment opportunities!

Market Cap	193K 173K 159K 144K 270K 18.37M 275K 1.9M 763K 9.66M 726K 710K 30.47M	P/E 2021	-11.9x	P/E 2022	-0.91x
Enterprise Value	22.55M 20.2M 18.58M 16.83M 31.47M 2.14B 32.06M 222M 88.94M 1.13B 84.63M 82.83M 3.55B	EV / Sales 2021	3,032,677x	EV / Sales 2022	5,906,865x
Free-Float	63.69%	Yield 2021 *	-	Yield 2022	-

31/05/24	Bloomios, Inc. Bankruptcy Case Dismissed	CI
15/04/24	Involuntary Petition Filed Against Bloomios, Inc.	CI
08/03/24	Bloomios, Inc. Ceases Manufacturing At the Facility and Terminated All Employees	CI
20/11/23	Bloomios, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
21/08/23	Bloomios, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
01/06/23	Bloomios, Inc. Provides Revenue Guidance for the Second Quarter of 2023	CI
19/05/23	Bloomios, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
17/04/23	Bloomios, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	CI
17/04/23	Bloomios, Inc. Auditor Raises 'Going Concern' Doubt	CI
22/11/22	Bloomios, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI
15/11/22	Bloomios, Inc. announced that it has received $0.852941 million in funding	CI
31/10/22	Bloomios, Inc. Closes on an Offering of the Debentures	CI
27/10/22	Bloomios, Inc. acquired Infusionz, LLC from Upexi, Inc. for $23.5 million.	CI

29/03/24	Bloomios : Changes in Control - Form 8-K	PU
08/03/24	Bloomios : Material Event - Form 8-K	PU
09/06/23	Bloomios Appoints Kevin Henry as National Sales Director	PR
01/06/23	Bloomios Reports Q1 2023 Revenue up 30% Sequentially and 84% Y/Y to $2.75 Million	PR
17/04/23	BLOOMIOS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ

Current year	0		0
1 year	0		0
3 years	0		0
5 years	0		2.79
10 years	0		4.95

Manager	Title	Age	Since
Michael Hill CEO	Chief Executive Officer	49	30/11/2020
Barrett Evans DFI	Director of Finance/CFO	54	-

Bloomios, Inc. Stock

Stocks

BLMS

US0948571098

Healthcare Facilities & Services

Valuation: Bloomios, Inc.

Chart: Bloomios, Inc.

Latest news: Bloomios, Inc.

Press Releases: Bloomios, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Bloomios, Inc.

Latest insider transactions

Medical Farming

Financials

Company Profile

Director	Title	Age	Since
Michael Hill CHM	Chairman	49	-
Barrett Evans BRD	Director/Board Member	54	16/06/2021
John Bennett BRD	Director/Board Member	65	16/06/2021

Date	Insider	Type	Main position	Quantity	% Market Cap.	Importance
11/22/22 A	Douglas S Rohrer	Other	Chief Business Officer	551,697	4.1887%
12/15/21 A	Barrett Evans	Other	Chairperson	16,563	0.1304%
7/9/21 A	Bibi Daprile	Other		95	-	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BLOOMIOS, INC.	-.--%	-.--%	+200.00%	-88.89%	20.36K
CVS HEALTH CORPORATION	-0.09%	-3.44%	+17.68%	+32.70%	115B
HCA HEALTHCARE, INC.	-1.02%	+0.89%	+1.37%	+111.87%	98.85B
NATERA, INC.	-4.98%	+2.56%	+114.42%	+1,003.33%	59.72B
LABCORP HOLDINGS INC.	-1.84%	+9.86%	+43.22%	+82.37%	29.34B
FRESENIUS SE & CO. KGAA	+1.44%	+1.95%	-6.67%	+93.57%	30.06B
QUEST DIAGNOSTICS INCORPORATED	-0.43%	+4.11%	+43.28%	+94.59%	27.71B
TENET HEALTHCARE CORPORATION	+0.99%	+1.79%	+30.98%	+413.15%	22B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	-0.72%	+5.53%	-18.63%	-12.38%	20.66B
IHH HEALTHCARE	0.00%	-0.63%	-4.27%	+31.71%	17.09B
Average	-0.66%	+2.26%	+42.14%	+176.20%	42.09B
Weighted average by Cap.	-1.01%	+1.07%	+27.33%	+218.55%

	2021	2022
Net sales	8.49 7.61 7 6.34 11.85 806.29 12.07 83.42 33.49 424.13 31.87 31.19 1.34K	6.08 5.44 5.01 4.54 8.48 577.02 8.64 59.7 23.97 303.53 22.81 22.32 957.23
Net income	-2.01M -1.8M -1.66M -1.5M -2.81M -191M -2.86M -19.76M -7.93M -100M -7.55M -7.39M -317M	-13.77M -12.34M -11.35M -10.28M -19.22M -1.31B -19.58M -135M -54.32M -688M -51.69M -50.59M -2.17B
Net Debt	1.62M 1.45M 1.33M 1.21M 2.26M 154M 2.3M 15.9M 6.38M 80.83M 6.07M 5.94M 255M	22.36M 20.02M 18.42M 16.69M 31.2M 2.12B 31.78M 220M 88.17M 1.12B 83.91M 82.12M 3.52B